Mark Litton
Overview
Mark Litton received an average of $3M in total compensation, including $526K in salary, at Athira Pharma from 2021 to 2023. Mark Litton also received $985K at Nivalis Therapeutics in 2018.
Source: SEC filings on April 9, 2024, April 5, 2023, and April 24, 2019.
Related executives
We found ten more executives who work or worked at Athira Pharma and Nivalis Therapeutics.
Andrew Gengos
Athira Pharma
Chief Financial Officer
Hans Moebius
Athira Pharma
Chief Medical Officer
Rachel Lenington
Athira Pharma
Chief Operating Officer
Mitchell Gold
Nivalis Therapeutics
Chief Executive Officer
Stanford Peng
Nivalis Therapeutics
President and Head of Research and Development
Zelanna Goldberg
Nivalis Therapeutics
Chief Medical Officer
Paul Rickey
Nivalis Therapeutics
Chief Financial Officer
Janice Troha
Nivalis Therapeutics